FDA Gives Clearance to World's First Deep-Learning Solution to Assist Workflow Triage

A brain solution that works with radiologists to flag acute intracranial hemorrhage (ICH) cases in head CTs and is the world's first deep-learning solution to assist radiologists in workflow triage has been granted clearance by the Food and Drug Administration (FDA). The product is the first of the expanding suite of artificial intelligence (AI)-based workflow optimization solutions to be offered by Aidoc (Tel-Aviv, Israel), a provider of AI solutions for radiologists.

Aidoc develops AI solutions that support and enhance the impact of radiologist diagnostic power, helping them expedite patient treatment and improve quality of care. The company's solutions reduce turnaround time and increase quality and efficiency by flagging acute anomalies in real time. Radiologists benefit from state-of-the art deep-learning technology that runs "behind the scenes" freeing them to focus on the diagnosis itself. Aidoc's healthcare-grade deep-learning algorithms benefit from large quantities of data, making their solutions the most comprehensive in the field, and enabling them to provide diagnostic aid to the broadest set of pathologies.

According to studies, over 75% of all patient care involves radiology, resulting in growing amount of imaging, although the number of radiologists is falling far short of the requirement. Radiologists are under increasing pressure to produce quality results more quickly with increasing amounts of data, but lack the necessary tools. Aidoc provides advanced solutions for radiologists to increase efficiency and expedite patient care within their existing work environment.

Aidoc's solution analyzes medical images directly after the patient is scanned and notifies the radiologist about cases with suspected findings to assist in the prioritization of time-sensitive and potentially life-threatening cases. Aidoc's solutions have been commercialized outside the US since December 2017 and are already deployed in over 50 medical centers worldwide, where they are used daily, analyzing over one million exams every year. The company is now in the process of obtaining FDA clearance for the remainder of its solutions, which will assist in the detection of a broad set of acute pathologies across the body.

"We decided to focus our solution on acute pathologies where quality of care and time are of the essence," said Aidoc's CEO Elad Walach. "Radiologists are challenged with responding to large numbers of acute cases in a timely fashion. The key, we believe, is to be comprehensive. If you really want to impact the daily practice you have to cover a significant portion of the radiologist's workflow. Our solution can sift through the whole worklist in the background and highlight cases that require immediate attention, improving radiologist's response time."

Related Links:
Aidoc